No Data
No Data
No Data
No Data
No Data
Xiangxue Pharmaceutical (300147.SZ) announced first-quarter results, changing profit to loss of 35.66 million yuan
Xiangxue Pharmaceutical (300147.SZ) released its report for the first quarter of 2024. The company's revenue was 5.69...
Zhitong FinanceApr 30 00:44
Express News | Xiangxue Pharmaceutical and others were forcibly charged 290 million
BreakingsApr 3 12:45
The innovative medicine sector rebounded and Osecon rose or stopped
Gelonghui, March 27 | Osecon rose and stopped, and Xiangxue Pharmaceutical, First Pharmaceutical Holdings, Yakshi Technology, and Chengdu Pioneer followed suit. According to the news, at the 2024 Annual Meeting of the China Development High-Level Forum held a few days ago, major industry experts said that the development of China's biomedical industry already has a good foundation, and an ecological environment encouraging the development of innovative drugs is being formed.
Gelonghui FinanceMar 27 10:34
Express News | Xiangxue Pharmaceuticals was forced to execute 248 million
BreakingsMar 26 14:13
The A-share Chinese medicine sector declined, and Xiangxue Pharmaceutical fell more than 5%
Gelonghui, March 13 | Datang Pharmaceutical and Xiangxue Pharmaceutical fell more than 5%, while Xintian Pharmaceutical, Biogu, Weikang Pharmaceutical, Teyi Pharmaceutical, and Xinguang Pharmaceutical followed suit.
Gelonghui FinanceMar 13 09:46
Express News | Xiangxue Pharmaceutical: TAEST16001 injection new application clinical trial accepted
BreakingsFeb 7 16:31
No Data
No Data